Skip to main content
main-content

Latest news

Neuer Inhalt Free registration

Gain full access to the latest clinical content available from Springer Nature

Breaking headlines, in-depth features, hot topic review articles, and 

the latest from major international conferences brought to you by


Editors' pick

20-02-2018 | Osteoarthritis | News

Trial results do not support hydroxychloroquine for hand OA

Results of the HERO trial suggest that the addition of hydroxychloroquine to standard care does not further reduce pain among patients with hand osteoarthritis .

Source:

Ann Intern Med 2018; Advance online publication

Latest headlines

22-02-2018 | Systemic lupus erythematosus | News

Long-term results confirm sustained benefits of belimumab in SLE patients

Results of the BLISS-76 continuation study suggest that long-term treatment with belimumab alongside standard care is associated with sustained efficacy and a stable adverse event profile among patients with systemic lupus erythematosus.

Source:

Arthritis Rheumatol 2018; Advance online publication

21-02-2018 | Rheumatoid arthritis | News

News in brief

Methotrexate associated with reduced dementia risk in RA patients

The use of conventional DMARDs, especially methotrexate, is associated with a reduced risk for dementia among patients with rheumatoid arthritis, researchers report.

20-02-2018 | Osteoarthritis | News

Trial results do not support hydroxychloroquine for hand OA

Results of the HERO trial suggest that the addition of hydroxychloroquine to standard care does not further reduce pain among patients with hand osteoarthritis .

Source:

Ann Intern Med 2018; Advance online publication

19-02-2018 | Psoriatic arthritis | News

Secukinumab boosts chances of minimal disease activity for PsA patients

Patients with psoriatic arthritis who are treated with the interkeukin-17 inhibitor secukinumab have an increased likelihood of achieving minimal disease activity, suggests an analysis of data from the FUTURE 2 trial.

Source:

Arthritis Care Res 2018; Advance online publication

16-02-2018 | Rheumatoid arthritis | News

Head-to-head trials of IL-6 inhibitors warranted in RA patients

Different biologic agents targeting the interleukin-6 signaling pathway may have distinct efficacy profiles in patients with rheumatoid arthritis, South Korean researchers report.

Source:

Clin Rheumatol 2018; Advance online publication

15-02-2018 | Juvenile idiopathic arthritis | News

Ultrasound helps predict flare risk in patients with JIA

Ultrasound abnormalities during clinical remission are a strong signal of future flare risk in patients with juvenile idiopathic arthritis, suggest researchers.

Source:

Ann Rheum Dis 2018; Advance online publication

In depth

09-02-2018 | Rheumatoid arthritis | Feature | News

Should treatment be tapered in patients with RA?

medwireNews speaks to Vivian Bykerk about whether treatment should be tapered in patients with rheumatoid arthritis.

13-12-2017 | Biosimilars | Feature | Article

Biosimilars: The story so far

medwireNews provides an overview of the evidence supporting the equivalence of biosimilar drugs and their reference products, and answers some questions about the use of biosimilars in rheumatology.

10-10-2017 | Juvenile idiopathic arthritis | Feature | Article

Talking point: Are biologics over-used in the treatment of JIA?

Timothy Beukelman speaks to medwireNews about the differing viewpoints on whether biologic treatments are over-used for the treatment of children with juvenile idiopathic arthritis.

image credits